Cynthia Pussinen
Chief Executive Officer at SERNOVA CORP.
Net worth: - $ as of 2024-03-30
Cynthia Pussinen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SERNOVA CORP. | Director/Board Member | 2023-09-04 | - |
| Chief Executive Officer | 2023-09-04 | - |
Career history of Cynthia Pussinen
Former positions of Cynthia Pussinen
| Companies | Position | Start | End |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-01-31 | 2022-11-30 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Training of Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Cynthia Pussinen
- Experience
